I often wonder should Marker have disclosed how cost effective the therapy is to manufacture. Seems to me like they have essentially let everyone know you can undercut the cost of other therapies.
Plus the lower price May lower expectations for revenue generation potential. Random thought but figured I would share with the board.
News 
Market Data 
Discover 
